Ftse Mib
33.235,42
-0,24%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
64.996,38
-0,22%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vanda Pharmaceuticals Inc (VNDA) Vanda Pharmaceuticals Inc (VNDA) Notizie

Vanda Pharmaceuticals Inc

VNDA
6,4491
0,0991 (1,56%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/6/202422:38EDGAR2Form 8-K - Current report
13/6/202416:02PRNUSVanda Pharmaceuticals Confirms Receipt of Revised..
06/6/202422:30EDGAR2Form 8-K - Current report
06/6/202415:24PRNUSVanda Pharmaceuticals Confirms Receipt of Unsolicited,..
30/5/202423:20PRNUSVanda Pharmaceuticals Announces Participation in the..
30/5/202422:48PRNUSVanda Pharmaceuticals Announces Completion of Transfer of..
29/5/202420:17PRNUSVanda Pharmaceuticals Announces Presentations at SLEEP 2024
24/5/202422:49EDGAR2Form 8-K - Current report
24/5/202422:46PRNUSVanda Pharmaceuticals Board of Directors Determines that..
24/5/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:31EDGAR2Form 8-K/A - Current report: [Amend]
21/5/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/5/202423:26EDGAR2Form 8-K - Current report
15/5/202414:45PRNUSVanda Pharmaceuticals Reports Positive Results from a Second..
13/5/202422:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/5/202423:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/5/202413:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:06EDGAR2Form 8-K - Current report
08/5/202422:01PRNUSVanda Pharmaceuticals Reports First Quarter 2024 Financial..
07/5/202422:51EDGAR2Form 8-K - Current report
07/5/202417:16PRNUSVanda Pharmaceuticals Confirms Receipt of Revised..
30/4/202422:30PRNUSVanda Pharmaceuticals to Announce First Quarter 2024..
25/4/202414:05GLOBEShareholder Capital Delivers Letter to Independent Members..
23/4/202401:13PRNUSVanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial..
17/4/202416:21PRNUSVanda Pharmaceuticals Adopts Limited Duration Stockholder..
17/4/202415:02PRNUSVanda Pharmaceuticals Confirms Rejection of Unsolicited..
03/4/202416:25APSBiotech Catches Major Premarket Bid Following FDA Approval
03/4/202400:10PRNUSVanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S...
07/3/202422:31EDGAR2Form 8-K - Current report
06/3/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:00PRNUSVanda Pharmaceuticals Announces FDA Update for supplemental..
05/3/202403:14EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:12EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:10EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:08EDGAR2Form 144 - Report of proposed sale of securities
05/3/202403:06EDGAR2Form 144 - Report of proposed sale of securities
21/2/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:32EDGAR2Form 8-K - Current report
16/2/202422:31EDGAR2Form 8-K/A - Current report: [Amend]
Apertura: 6,41 Min: 6,1778 Max: 6,44
Chiusura: 6,35

La tua Cronologia

NASDAQ
VNDA
Vanda Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network